On Monday, January 7, the next meeting of the AOTMiT Transparency Council.
The agenda includes:
1 Prepare a position on the removal of the health care service "Collection of material from the cervix for cytological screening (classic cytology)".
2 Prepare a position paper on the evaluation of the drug Alecensa (alectinib) under the drug program "Treatment of patients with lung cancer (ICD-10 C34) and pleural mesothelioma (ICD-10 C45)".
3 Prepare a position paper on the evaluation of the drug Forxiga (dapagliflozinum) for the indication: chronic heart failure.
4. Preparation of a position paper on the examination of the legitimacy of issuing approvals for reimburse...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
